Anita Nagy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anita Nagy has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Gino R. Somers
Division of Pathology, The Hospital for Sick Children, Toronto, ON, Canada
2 shared publications - Haiying Chen
Division of Pathology, The Hospital for Sick Children, Toronto, ON, Canada
2 shared publications - Jeanette A. Reyes
Department of Paediatric Laboratory Medicine, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada
2 shared publications Jing Li
Division of Cardiovascular Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada
2 shared publications- Juan Putra
Department of Pathology Boston Children's Hospital, and Harvard Medical School Boston Massachusetts USA
2 shared publications Marlee Parker
Division of Perfusion Services, The Hospital for Sick Children, Toronto, Ontario, Canada
2 shared publications
Latest Publications
- 22 October 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Ex Vivo Heart Perfusion Versus Cold Storage in Prolonged Preservation Period: A Juvenile Porcine Experimental Model
Cross-clamp times greater than or equal to 4 hours are critical for donor heart viability. We compared cold storage (CS) and normothermic ex vivo heart perfusion (EVHP) during prolonged preservation using a juvenile porcine model. Twenty-two piglet hearts (~10 kg) were assigned to CS or EVHP for 6 or 8 hours, followed by 2 hours of working-mode (WM) perfusion. Metabolism, cardiac function, and cell damage were compared using two-sample t-tests or Fisher’s exact tests, and temporal changes during perfusion were assessed using linear mixed-effects models and generalized estimating equations. During EVHP, the minimal rate of pressure change decreased, and arterial lactate levels increased after 5–6 hours. Compared to CS, EVHP hearts showed higher left atrial pressure (6 vs. 0 mm Hg, p = 0.011), arterial lactate levels during WM ( p < 0.001), and NFκB-p65 levels ( p = 0.002) at 6 hours, and lower cardiac output (90 vs. 120% of normal, p = 0.026), higher left atrial pressure (7 vs. 3 mm Hg, p = 0.009), higher arterial lactate levels during WM ( p < 0.001), and increased neutrophil infiltration ( p = 0.033) at 8 hours. Ex vivo heart perfusion hearts deteriorated beyond 5–6 hours and showed greater hemodynamic, metabolic, and inflammatory changes at both 6 and 8 hours. Ex vivo heart perfusion enhancements reducing immune response and inflammation are crucial for expanding the donor pool.
- 22 October 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Ex Vivo Heart Perfusion Versus Cold Storage in Prolonged Preservation Period: A Juvenile Porcine Experimental Model
Cross-clamp times greater than or equal to 4 hours are critical for donor heart viability. We compared cold storage (CS) and normothermic ex vivo heart perfusion (EVHP) during prolonged preservation using a juvenile porcine model. Twenty-two piglet hearts (~10 kg) were assigned to CS or EVHP for 6 or 8 hours, followed by 2 hours of working-mode (WM) perfusion. Metabolism, cardiac function, and cell damage were compared using two-sample t-tests or Fisher’s exact tests, and temporal changes during perfusion were assessed using linear mixed-effects models and generalized estimating equations. During EVHP, the minimal rate of pressure change decreased, and arterial lactate levels increased after 5–6 hours. Compared to CS, EVHP hearts showed higher left atrial pressure (6 vs. 0 mm Hg, p = 0.011), arterial lactate levels during WM ( p < 0.001), and NFκB-p65 levels ( p = 0.002) at 6 hours, and lower cardiac output (90 vs. 120% of normal, p = 0.026), higher left atrial pressure (7 vs. 3 mm Hg, p = 0.009), higher arterial lactate levels during WM ( p < 0.001), and increased neutrophil infiltration ( p = 0.033) at 8 hours. Ex vivo heart perfusion hearts deteriorated beyond 5–6 hours and showed greater hemodynamic, metabolic, and inflammatory changes at both 6 and 8 hours. Ex vivo heart perfusion enhancements reducing immune response and inflammation are crucial for expanding the donor pool.
- Open Access
- 30 September 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (19) , 3189
Occult Neoplasms in Sudden Unexpected Death in Infancy: A Scoping Review of Post-Mortem Findings
Background: Sudden unexpected death in infancy (SUDI) may occasionally be attributable to neoplasms that were clinically unrecognised before the terminal event and diagnosed or confirmed during post-mortem investigation. These occult neoplasms are exceptionally rare and remain poorly characterised. This scoping review identifies published reports of neoplasms not diagnosed or strongly suspected before the terminal event in infants who died suddenly and unexpectedly, and systematically collects data on pathological features, diagnostic modalities, mechanisms of death, and the extent to which the neoplasm contributed to death. Methods: A search of PubMed/MEDLINE and Scopus was conducted without a lower publication-date restriction through 19 July 2026, in accordance with Joanna Briggs Institute guidance and PRISMA-ScR. Publications describing sudden unexpected deaths in infants younger than 12 months with a previously undiagnosed neoplasm were selected and reviewed. Findings were extracted, and deaths were classified according to whether the neoplasm was causal, contributory, or incidental to death. Results: Twenty-five studies comprising 32 infant cases were included in the review. The median age at death was 2.5 months. The most frequent lesions were cardiovascular or thoracic neoplasms (16/32), followed by haematological or lymphoid neoplasms (6/32). Sixteen lesions were benign, ten were malignant, and six were intermediate, uncertain, or tumour-like. Twenty-five neoplasms were evident on macroscopic examination, whereas seven were identified only histologically. Reported mechanisms of death included arrhythmia, mechanical obstruction, respiratory failure, haemodynamic compromise, haemorrhage, leukostasis, and diffuse infiltration. Within the published cases included in this review, the review team classified the neoplasm as causal in 16 cases (16/32, 50.0%), contributory in 13 cases (13/32, 40.6%), and incidental in three cases (3/32, 9.4%). Conclusions: Autopsy examination is critical for identifying previously undiagnosed neoplasms, which are rare but potentially important findings in the investigation of SUDI. Among the selected published cases included in this review, the review team classified the neoplasm as causal in half of cases; this proportion should not be extrapolated to the broader SUDI population. Comprehensive autopsy assessment of SUDI cases, including thorough histological sampling and ancillary testing, is therefore essential for determining the role of a tumour in infant death.
- 30 September 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (19) , 3189
Open AccessOccult Neoplasms in Sudden Unexpected Death in Infancy: A Scoping Review of Post-Mortem Findings
Background: Sudden unexpected death in infancy (SUDI) may occasionally be attributable to neoplasms that were clinically unrecognised before the terminal event and diagnosed or confirmed during post-mortem investigation. These occult neoplasms are exceptionally rare and remain poorly characterised. This scoping review identifies published reports of neoplasms not diagnosed or strongly suspected before the terminal event in infants who died suddenly and unexpectedly, and systematically collects data on pathological features, diagnostic modalities, mechanisms of death, and the extent to which the neoplasm contributed to death. Methods: A search of PubMed/MEDLINE and Scopus was conducted without a lower publication-date restriction through 19 July 2026, in accordance with Joanna Briggs Institute guidance and PRISMA-ScR. Publications describing sudden unexpected deaths in infants younger than 12 months with a previously undiagnosed neoplasm were selected and reviewed. Findings were extracted, and deaths were classified according to whether the neoplasm was causal, contributory, or incidental to death. Results: Twenty-five studies comprising 32 infant cases were included in the review. The median age at death was 2.5 months. The most frequent lesions were cardiovascular or thoracic neoplasms (16/32), followed by haematological or lymphoid neoplasms (6/32). Sixteen lesions were benign, ten were malignant, and six were intermediate, uncertain, or tumour-like. Twenty-five neoplasms were evident on macroscopic examination, whereas seven were identified only histologically. Reported mechanisms of death included arrhythmia, mechanical obstruction, respiratory failure, haemodynamic compromise, haemorrhage, leukostasis, and diffuse infiltration. Within the published cases included in this review, the review team classified the neoplasm as causal in 16 cases (16/32, 50.0%), contributory in 13 cases (13/32, 40.6%), and incidental in three cases (3/32, 9.4%). Conclusions: Autopsy examination is critical for identifying previously undiagnosed neoplasms, which are rare but potentially important findings in the investigation of SUDI. Among the selected published cases included in this review, the review team classified the neoplasm as causal in half of cases; this proportion should not be extrapolated to the broader SUDI population. Comprehensive autopsy assessment of SUDI cases, including thorough histological sampling and ancillary testing, is therefore essential for determining the role of a tumour in infant death.
- Open Access
- 9 October 2025
- Published by Wiley in Histopathology
- Vol. 88 (3) , 664-672
CDKN2A deletion in p16‐negative/ HPV ‐positive head and neck squamous cell carcinoma: Highlighting the molecular basis behind the limitation of relying on p16 immunohistochemistry as a surrogate marker for HPV involvement
Aims: Immunohistochemistry (IHC) for p16 is widely used as a surrogate marker for HPV involvement in oropharyngeal squamous cell carcinoma (OPSCC), among other tumours. Confirming HPV status in OPSCC is critical, as HPV‐positive tumours have better overall survival and may require de‐escalated therapy compared to HPV‐independent OPSCC in the future. However, discordance exists between p16 and HPV, and direct HPV testing is occasionally required to ensure an accurate diagnosis. The aim of this study is to highlight the genomic basis behind the limitation of relying on p16 IHC as a surrogate marker for HPV involvement. Methods and Results: Through a multi‐institutional collaboration, this case series compiled four patients with a ‘false’ negative p16 staining pattern in HPV‐positive non‐keratinizing head and neck squamous cell carcinoma. All cases demonstrated minimal to no p16 IHC staining and were positive for HPV by direct RNA in situ hybridization. Through CDKN2A fluorescence in situ hybridization testing, three patients demonstrated a homozygous deletion of CDKN2A and one demonstrated a heterozygous deletion. Conclusions: This series highlights the genomic basis for the ‘false’ negative p16 results, raising awareness of a significant diagnostic pitfall while emphasizing the importance of careful consideration of clinicopathologic parameters in the clinical workup of these cases.
- 9 October 2025
- Published by Wiley in Histopathology
- Vol. 88 (3) , 664-672
Open AccessCDKN2A deletion in p16‐negative/ HPV ‐positive head and neck squamous cell carcinoma: Highlighting the molecular basis behind the limitation of relying on p16 immunohistochemistry as a surrogate marker for HPV involvement
Aims: Immunohistochemistry (IHC) for p16 is widely used as a surrogate marker for HPV involvement in oropharyngeal squamous cell carcinoma (OPSCC), among other tumours. Confirming HPV status in OPSCC is critical, as HPV‐positive tumours have better overall survival and may require de‐escalated therapy compared to HPV‐independent OPSCC in the future. However, discordance exists between p16 and HPV, and direct HPV testing is occasionally required to ensure an accurate diagnosis. The aim of this study is to highlight the genomic basis behind the limitation of relying on p16 IHC as a surrogate marker for HPV involvement. Methods and Results: Through a multi‐institutional collaboration, this case series compiled four patients with a ‘false’ negative p16 staining pattern in HPV‐positive non‐keratinizing head and neck squamous cell carcinoma. All cases demonstrated minimal to no p16 IHC staining and were positive for HPV by direct RNA in situ hybridization. Through CDKN2A fluorescence in situ hybridization testing, three patients demonstrated a homozygous deletion of CDKN2A and one demonstrated a heterozygous deletion. Conclusions: This series highlights the genomic basis for the ‘false’ negative p16 results, raising awareness of a significant diagnostic pitfall while emphasizing the importance of careful consideration of clinicopathologic parameters in the clinical workup of these cases.
- Open Access
- 27 June 2025
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 28 (5) , 435-437
A Retrospective Review of Autopsy Data From 6 North American Institutions Indicates Practice Variations That Could Be Leveraged to Address Declining Autopsy Rates
- 27 June 2025
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 28 (5) , 435-437
Open AccessA Retrospective Review of Autopsy Data From 6 North American Institutions Indicates Practice Variations That Could Be Leveraged to Address Declining Autopsy Rates
- Open Access
- 10 February 2025
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 28 (3) , 164-171
Validation of A Nationwide Digital Pediatric Pathology Consultation Network
Background: Digital pathology facilitates remote pathology consultations. Pediatric pathologists in Canada formed a nationwide digital pathology consultation network, mostly for second opinion review of pediatric cancer cases. Validation of such a large network for clinical use is challenging. Here we report our unique validation process of this digital pathology network. Method: This study was designed in keeping with the College of American Pathologist (CAP) guidelines, and included 14 pathologists from 9 hospitals across Canada. All cases are pediatric pathology cases. Each pathologist reviewed multiple digital cases and the corresponding glass slide cases. For each review, intra-observer concordance (diagnosis on digital case versus diagnosis on glass slide case) was recorded, creating a data point. Result: The study generated 269 valid diagnostic data points. Out of the 269 data points, 257 were concordant (95.5% concordance), exceeding the CAP recommendation of 95% concordance. Thus, the network was successfully validated. Conclusion: This is a unique validation study for a large nationwide digital pediatric pathology network. The study involved all pathologists/hospitals in the network, closely emulating real world clinical process. The network was successfully validated.
- 10 February 2025
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 28 (3) , 164-171
Open AccessValidation of A Nationwide Digital Pediatric Pathology Consultation Network
Background: Digital pathology facilitates remote pathology consultations. Pediatric pathologists in Canada formed a nationwide digital pathology consultation network, mostly for second opinion review of pediatric cancer cases. Validation of such a large network for clinical use is challenging. Here we report our unique validation process of this digital pathology network. Method: This study was designed in keeping with the College of American Pathologist (CAP) guidelines, and included 14 pathologists from 9 hospitals across Canada. All cases are pediatric pathology cases. Each pathologist reviewed multiple digital cases and the corresponding glass slide cases. For each review, intra-observer concordance (diagnosis on digital case versus diagnosis on glass slide case) was recorded, creating a data point. Result: The study generated 269 valid diagnostic data points. Out of the 269 data points, 257 were concordant (95.5% concordance), exceeding the CAP recommendation of 95% concordance. Thus, the network was successfully validated. Conclusion: This is a unique validation study for a large nationwide digital pediatric pathology network. The study involved all pathologists/hospitals in the network, closely emulating real world clinical process. The network was successfully validated.
- 26 December 2024
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (1) , e27444
Successful Management of Pediatric Endobronchial Tuberculosis With Endoscopic Cryotherapy: A Case Series
- 26 December 2024
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (1) , e27444
Successful Management of Pediatric Endobronchial Tuberculosis With Endoscopic Cryotherapy: A Case Series
- 10 October 2024
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 269, 482-487
Pediatric Eyelid Cutaneous Horns: A Case Series and Literature Review
- 10 October 2024
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 269, 482-487
Pediatric Eyelid Cutaneous Horns: A Case Series and Literature Review
- Open Access
- 24 February 2024
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 27 (4) , 335-339
A Pediatric Primary Cardiac Spindle Cell Neoplasm With a Rare PDGFRA::USP8 Gene Fusion: A Case Report
We report a case of a primary cardiac spindle cell neoplasm with concerning histological features and a rare PDGFRA::USP8 gene fusion in a 3 year old boy. The patient presented with a large cardiac mass predominantly in the right ventricle, originating from the ventricular septum. The mass was resected with grossly negative margins. Pathology revealed an unclassified spindle cell neoplasm with a PDGFRA::USP8 gene fusion. This gene fusion has only been previously reported twice in the medical literature, one in a pediatric cardiac sarcoma and the other in an abdominal soft tissue tumor in an adult woman. The patient is alive and well with no evidence of recurrence 11 months after excision.
- 24 February 2024
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 27 (4) , 335-339
Open AccessA Pediatric Primary Cardiac Spindle Cell Neoplasm With a Rare PDGFRA::USP8 Gene Fusion: A Case Report
We report a case of a primary cardiac spindle cell neoplasm with concerning histological features and a rare PDGFRA::USP8 gene fusion in a 3 year old boy. The patient presented with a large cardiac mass predominantly in the right ventricle, originating from the ventricular septum. The mass was resected with grossly negative margins. Pathology revealed an unclassified spindle cell neoplasm with a PDGFRA::USP8 gene fusion. This gene fusion has only been previously reported twice in the medical literature, one in a pediatric cardiac sarcoma and the other in an abdominal soft tissue tumor in an adult woman. The patient is alive and well with no evidence of recurrence 11 months after excision.
- 7 February 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (3) , e027163
Cardioprotective Actions of a Glucagon‐like Peptide‐1 Receptor Agonist on Hearts Donated After Circulatory Death
Background: Heart transplantation with a donation after circulatory death (DCD) heart is complicated by substantial organ ischemia and ischemia–reperfusion injury. Exenatide, a glucagon‐like peptide−1 receptor agonist, manifests protection against cardiac ischemia–reperfusion injury in other settings. Here we evaluate the effects of exenatide on DCD hearts in juvenile pigs. Methods and Results: DCD hearts with 15‐minutes of global warm ischemia after circulatory arrest were reperfused ex vivo and switched to working mode. Treatment with concentration 5‐nmol exenatide was given during reperfusion. DCD hearts treated with exenatide showed higher myocardial oxygen consumption (exenatide [n=7] versus controls [n=7], over 60–120 minutes of reperfusion, P P =0.04) during reperfusion compared with controls. In working mode, exenatide‐treated hearts showed better diastolic function (dp/dt min: −3644±620 versus −2193±610 mm Hg/s, P P =0.02; lateral e ′ velocity: 11.27 ± 1.46 versus 7.19±2.96, P =0.01), as well as lower venous lactate levels (3.17±0.75 versus 5.17±1.44 mmol/L, P =0.01) compared with controls. Higher levels of activated endothelial nitric oxide synthase (phosphorylated to total endothelial nitric oxide synthase levels: 2.71±1.16 versus 1.37±0.35, P =0.02) with less histological evidence of endothelial damage (von Willebrand factor expression: 0.024±0.007 versus 0.331±0.302, pixel/μm, P =0.04) was also observed with exenatide treatment versus controls. Conclusions: Acute treatment of DCD hearts with exenatide limits myocardial and endothelial injury and improves donor cardiac function.
- 7 February 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (3) , e027163
Cardioprotective Actions of a Glucagon‐like Peptide‐1 Receptor Agonist on Hearts Donated After Circulatory Death
Background: Heart transplantation with a donation after circulatory death (DCD) heart is complicated by substantial organ ischemia and ischemia–reperfusion injury. Exenatide, a glucagon‐like peptide−1 receptor agonist, manifests protection against cardiac ischemia–reperfusion injury in other settings. Here we evaluate the effects of exenatide on DCD hearts in juvenile pigs. Methods and Results: DCD hearts with 15‐minutes of global warm ischemia after circulatory arrest were reperfused ex vivo and switched to working mode. Treatment with concentration 5‐nmol exenatide was given during reperfusion. DCD hearts treated with exenatide showed higher myocardial oxygen consumption (exenatide [n=7] versus controls [n=7], over 60–120 minutes of reperfusion, P P =0.04) during reperfusion compared with controls. In working mode, exenatide‐treated hearts showed better diastolic function (dp/dt min: −3644±620 versus −2193±610 mm Hg/s, P P =0.02; lateral e ′ velocity: 11.27 ± 1.46 versus 7.19±2.96, P =0.01), as well as lower venous lactate levels (3.17±0.75 versus 5.17±1.44 mmol/L, P =0.01) compared with controls. Higher levels of activated endothelial nitric oxide synthase (phosphorylated to total endothelial nitric oxide synthase levels: 2.71±1.16 versus 1.37±0.35, P =0.02) with less histological evidence of endothelial damage (von Willebrand factor expression: 0.024±0.007 versus 0.331±0.302, pixel/μm, P =0.04) was also observed with exenatide treatment versus controls. Conclusions: Acute treatment of DCD hearts with exenatide limits myocardial and endothelial injury and improves donor cardiac function.
- Open Access
- 28 February 2022
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 25 (4) , 409-418
Fatal Pediatric Streptococcal Infection: A Clinico—Pathological Study
Purpose and Context: Streptococcal Infection (SI) is an important cause of pediatric death in children, yet limited reports exist on autopsy findings in fatal SI cases. Method: Case records (1997–2019) of SI with no pre-existing risk factors were reviewed and selected. Their clinical and pathological findings in the autopsy reports were analyzed. Results: In our cohort of 38 cases based on bacterial culture results, SI was most commonly caused by Streptococcus pneumoniae (SPn; 45%) and Streptococcus pyogenes (SPy; 37%). 92% of decedents had some prodromal symptoms prior to terminal presentation. The clinical course was often rapid, with 89% found unresponsive, suddenly collapsing, or dying within 24 hours of hospital admission. 64% of deaths were attributed to sepsis, more frequently diagnosed in the SPy group than in the SPn group (71% vs 48%). Pneumonia was found in both SPn and SPy groups, whereas meningitis was exclusively associated with SPn. Conclusion: Our study shows fatal SI is most commonly caused by either SPn or SPy, both of which are frequently associated with prodromal symptoms, rapid terminal clinical course, and evidence of sepsis. Postmortem diagnosis of sepsis is challenging and should be correlated with clinical features, bacterial culture results, and autopsy findings.
- 28 February 2022
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 25 (4) , 409-418
Open AccessFatal Pediatric Streptococcal Infection: A Clinico—Pathological Study
Purpose and Context: Streptococcal Infection (SI) is an important cause of pediatric death in children, yet limited reports exist on autopsy findings in fatal SI cases. Method: Case records (1997–2019) of SI with no pre-existing risk factors were reviewed and selected. Their clinical and pathological findings in the autopsy reports were analyzed. Results: In our cohort of 38 cases based on bacterial culture results, SI was most commonly caused by Streptococcus pneumoniae (SPn; 45%) and Streptococcus pyogenes (SPy; 37%). 92% of decedents had some prodromal symptoms prior to terminal presentation. The clinical course was often rapid, with 89% found unresponsive, suddenly collapsing, or dying within 24 hours of hospital admission. 64% of deaths were attributed to sepsis, more frequently diagnosed in the SPy group than in the SPn group (71% vs 48%). Pneumonia was found in both SPn and SPy groups, whereas meningitis was exclusively associated with SPn. Conclusion: Our study shows fatal SI is most commonly caused by either SPn or SPy, both of which are frequently associated with prodromal symptoms, rapid terminal clinical course, and evidence of sepsis. Postmortem diagnosis of sepsis is challenging and should be correlated with clinical features, bacterial culture results, and autopsy findings.